Grade 1 urothelial carcinoma versus PUNLMP: Current status

Lina Liu, Liang Cheng

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Nearly half of all bladder tumors are noninvasive (stage pTa) papillary neoplasms of urothelial origin. Histologic grading is one of the most important variables for a clinician to successfully manage such patients. However, contemporary classification and grading of papillary urothelial neoplasms remains unsettled. The purpose of this article is to provide current information with an emphasis on grade 1 urothelial carcinoma versus papillary urothelial carcinoma of low malignant potential (PUNLMP). The World Health Organization [WHO (1973)] classification for papillary urothelial neoplasms (papilloma, grade 1, grade 2, and grade 3 carcinoma) is still most often used compared with existing alternatives [such as WHO/International Society of Urological Pathology (1998), WHO (1999), and WHO (2004)]. The new terminology (PUNLMP) used in the WHO (2004) classification is of unproven validity and utility. Recent advances in the molecular grading of these tumors may soon supplant traditional morphologic classification, allowing a more precise and objective assessment of the biologic potential of these tumors.

Original languageEnglish (US)
Pages (from-to)144-148
Number of pages5
JournalPathology Case Reviews
Issue number4
StatePublished - Jul 1 2008


  • Histologic grading
  • Papillary urothelial neoplasm
  • WHO classification

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Grade 1 urothelial carcinoma versus PUNLMP: Current status'. Together they form a unique fingerprint.

Cite this